why GE HealthCare Technologies Inc [GEHC] is a Good Choice for Investors After New Price Target of $94.09

GE HealthCare Technologies Inc [NASDAQ: GEHC] stock went on an upward path that rose over 1.04% on Wednesday, amounting to a one-week price decrease of less than -0.04%. The company report on April 3, 2024 at 8:00 AM that GE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images.

Caption AI on Vscan Air SL expands access to cardiac care by enabling more medical professionals to feel confident acquiring images for rapid assessments.

AutoEF feature automatically calculates ejection fraction, saving time for clinicians while delivering key information for making their diagnoses.

Over the last 12 months, GEHC stock rose by 8.53%. The one-year GE HealthCare Technologies Inc stock forecast points to a potential upside of 5.38. The average equity rating for GEHC stock is currently 1.82, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $40.54 billion, with 455.34 million shares outstanding and 421.28 million shares in the current float. Compared to the average trading volume of 3.61M shares, GEHC stock reached a trading volume of 4403381 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on GE HealthCare Technologies Inc [GEHC]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GEHC shares is $94.09 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GEHC stock is a recommendation set at 1.82. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

HSBC Securities have made an estimate for GE HealthCare Technologies Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 15, 2024. While these analysts kept the previous recommendation, UBS raised their target price from $66 to $88. The new note on the price target was released on February 12, 2024, representing the official price target for GE HealthCare Technologies Inc stock. Previously, the target price had yet another raise to $80, while Jefferies analysts kept a Hold rating on GEHC stock. On November 27, 2023, analysts decreased their price target for GEHC shares from 86 to 66.

The Average True Range (ATR) for GE HealthCare Technologies Inc is set at 1.94, with the Price to Sales ratio for GEHC stock in the period of the last 12 months amounting to 2.07. The Price to Book ratio for the last quarter was 5.68, with the Price to Cash per share for the same quarter was set at 5.50. Price to Free Cash Flow for GEHC in the course of the last twelve months was 23.65 with Quick ratio for the last quarter at 0.78.

GEHC Stock Performance Analysis:

GE HealthCare Technologies Inc [GEHC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.04. With this latest performance, GEHC shares dropped by -3.99% in over the last four-week period, additionally plugging by 31.24% over the last 6 months – not to mention a rise of 8.53% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GEHC stock in for the last two-week period is set at 50.20, with the RSI for the last a single of trading hit 46.21, and the three-weeks RSI is set at 53.48 for GE HealthCare Technologies Inc [GEHC]. The present Moving Average for the last 50 days of trading for this stock 85.68, while it was recorded at 89.58 for the last single week of trading, and 75.64 for the last 200 days.

Insight into GE HealthCare Technologies Inc Fundamentals:

GE HealthCare Technologies Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.78 and a Current Ratio set at 1.00.

GEHC Stock EPS

With the latest financial reports released by the company, GE HealthCare Technologies Inc posted 0.85/share EPS, while the average EPS was predicted by analysts to be reported at 0.79/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 7.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GEHC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for GE HealthCare Technologies Inc go to 12.10%.

GE HealthCare Technologies Inc [GEHC] Institutonal Ownership Details

The top three institutional holders of GEHC stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in GEHC stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in GEHC stock with ownership which is approximately 5.8386%.